| A histone deacetylase inhibitor enhances expression of genes inhibiting Wnt pathway and augments activity of DNA demethylation reagent against nonsmall‐cell lung cancer JM Shieh, YA Tang, FH Hu, WJ Huang, YJ Wang, J Jen, SY Liao, YH Lu, ... International journal of cancer 140 (10), 2375-2386, 2017 | 30 | 2017 |
| A prognostic predictor panel with DNA methylation biomarkers for early-stage lung adenocarcinoma in Asian and Caucasian populations IY Kuo, J Jen, LH Hsu, HS Hsu, WW Lai, YC Wang Journal of biomedical science 23, 1-10, 2016 | 15 | 2016 |
| Abstract A30: Oncogenic MCT-1 activation deregulates oxidative metabolism and promotes lung tumor progression and metastasis HY Tseng, YA Chen, J Jen, YC Wang, HL Hsu Cancer Research 77 (6_Supplement), A30-A30, 2017 | | 2017 |
| CK1δ/GSK3β/FBXW7α axis promotes degradation of the ZNF322A oncoprotein to suppress lung cancer progression SY Liao, CW Chiang, CH Hsu, YT Chen, J Jen, HF Juan, WW Lai, ... Oncogene 36 (41), 5722-5733, 2017 | 13 | 2017 |
| Combined inhibition of SHP2 and CXCR1/2 promotes antitumor T-cell response in NSCLC KH Tang, S Li, A Khodadadi-Jamayran, J Jen, H Han, K Guidry, T Chen, ... Cancer discovery 12 (1), 47-61, 2022 | 66 | 2022 |
| Combined Inhibition of SHP2 and CXCR1/2 Promotes Antitumor T-cell Response in NSCLC. Cancer Discov 12, 47–61, doi: 10.1158/2159-8290 KH Tang, S Li, A Khodadadi-Jamayran, J Jen, H Han, K Guidry, T Chen, ... CD-21-0369, 2022 | 4 | 2022 |
| Combined inhibition of SHP2 and CXCR1/2 promotes antitumor T-cell response in NSCLC. Cancer Discov. 2022; 12: 47–61. doi: 10.1158/2159-8290 KH Tang, S Li, A Khodadadi-Jamayran, J Jen, H Han, K Guidry, T Chen, ... CD-21-0369, 0 | 6 | |
| Cordycepin induced MA‐10 mouse Leydig tumor cell apoptosis through caspase‐9 pathway CY Jen, CY Lin, BM Huang, SF Leu Evidence‐Based Complementary and Alternative Medicine 2011 (1), 984537, 2011 | 58 | 2011 |
| Dysregulated Kras/YY1/ZNF322A/Shh transcriptional axis enhances neo-angiogenesis to promote lung cancer progression CC Lin, IY Kuo, LT Wu, WH Kuan, SY Liao, J Jen, YE Yang, CW Tang, ... Theranostics 10 (22), 10001, 2020 | 23 | 2020 |
| Effects of sesamol on apoptosis and steroidogenesis in MA-10 mouse Leydig tumor cells YH Chen, SF Leu, CY Jen, BM Huang Journal of agricultural and food chemistry 59 (18), 9885-9891, 2011 | 16 | 2011 |
| Erratum: Oncoprotein ZNF322A transcriptionally deregulates alpha-adducin, cyclin D1 and p53 to promote tumor growth and metastasis in lung cancer J Jen, LL Lin, FY Lo, HT Chen, SY Liao, YA Tang, WC Su, R Salgia, ... Oncogene 36 (36), 5219, 2017 | 47* | 2017 |
| OA12. 03 Combined Inhibition of SHP2 and CXCR1/2 Promotes Anti-Tumor T Cell Response in NSCLC S Li, K Tang, A Khodadadi-Jamayran, J Jen, H Han, K Guidry, T Chen, ... Journal of Thoracic Oncology 16 (10), S869, 2021 | | 2021 |
| Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression J Jen, YA Tang, YH Lu, CC Lin, WW Lai, YC Wang Molecular cancer 16, 1-12, 2017 | 204 | 2017 |
| Oncogenic MCT-1 activation promotes YY1-EGFR-MnSOD signaling and tumor progression HY Tseng, YA Chen, J Jen, PC Shen, LM Chen, TD Lin, YC Wang, ... Oncogenesis 6 (4), e313-e313, 2017 | 27 | 2017 |
| Oncogenic zinc finger protein ZNF322A promotes stem cell-like properties in lung cancer through transcriptional suppression of c-Myc expression J Jen, CY Liu, YT Chen, LT Wu, YC Shieh, WW Lai, YC Wang Cell Death & Differentiation 26 (7), 1283-1298, 2019 | 20 | 2019 |
| Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer CA Chang, J Jen, S Jiang, A Sayad, AS Mer, KR Brown, AML Nixon, ... Cancer discovery 12 (4), 1022-1045, 2022 | 66 | 2022 |
| Ontogeny and vulnerabilities of drug-tolerant persisters in HER2+ breast cancer. Cancer Discov 12: 1022–1045 CA Chang, J Jen, S Jiang, A Sayad, AS Mer, KR Brown, AML Nixon, ... | 5 | 2022 |
| SHP2 inhibition prevents adaptive resistance to MEK inhibitors in multiple cancer models C Fedele, H Ran, B Diskin, W Wei, J Jen, MJ Geer, K Araki, U Ozerdem, ... Cancer discovery 8 (10), 1237-1249, 2018 | 267 | 2018 |
| SHP2 Inhibition Prevents Adaptive Resistance to MEK Inhibitors in Multiple Cancer Models. Cancer Discov 2018; 8 (10): 1237-49 doi 10.1158/2159-8290 C Fedele, H Ran, B Diskin, W Wei, J Jen, MJ Geer CD-18-0444, 0 | 4 | |
| SHP2 inhibition prevents adaptive resistance to MEK inhibitors in multiple cancer models. Cancer Discov 8: 1237–1249 C Fedele, H Ran, B Diskin, W Wei, J Jen, MJ Geer, K Araki, U Ozerdem, ... | 9 | 2018 |
